Guardian Pharmacy Services, Inc. (GRDN) Income Statement
GRDN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsGRDN revenue and net income
Where GRDN's revenue goes
2025Each bar shows an amount and its share of revenue. GRDN kept 3.4% of revenue as net income.
GRDN profit margins
GRDN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +17.9% | +16.8% | +14.5% | — |
| Gross profit | +15.4% | +14.9% | +13.9% | — |
| Operating income | — | +19.6% | +22.6% | — |
| Net income | — | +11.6% | +19.8% | — |
| EPS (diluted) | +38.2% | +21.9% | +26.0% | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
GRDN quarterly EPS vs estimates
Guardian Pharmacy Services beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 9, 2026 (estimate $0.28).
GRDN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.45B | $1.23B | $1.05B | $908.9M | $792.1M | $736.0M | $698.3M | $600.4M |
| Cost of revenue | $1.17B | $984.0M | $837.9M | $723.0M | $630.8M | $589.0M | $554.8M | $477.3M |
| Gross profit | $282.0M | $244.4M | $208.3M | $185.9M | $161.3M | $147.0M | $143.5M | $123.0M |
| Sales, general & admin | $220.0M | $302.9M | $167.4M | $3.4M | $131.1M | $102.5M | $97.6M | $87.8M |
| Total operating expenses | $193.1M | $307.3M | $167.4M | $133.9M | $131.1M | $114.9M | $109.4M | $97.1M |
| Operating income | $88.9M | −$62.9M | $40.9M | $52.0M | $30.1M | $32.1M | $34.1M | $25.9M |
| Interest expense | $665,000 | $3.3M | $2.9M | $1.9M | $1.6M | $2.2M | $2.3M | $1.9M |
| Income before taxes | $73.4M | −$66.5M | $37.7M | $49.7M | $28.3M | $29.7M | $31.4M | $23.3M |
| Income taxes | $24.5M | $4.6M | — | — | — | — | — | — |
| Net income | $49.2M | −$87.3M | $23.9M | $35.4M | $16.3M | $19.9M | $21.7M | $14.7M |
| EBITDA | $96.4M | −$43.4M | $58.8M | $68.2M | $46.5M | $49.1M | $49.5M | $38.3M |
| EPS (diluted) | $1.05 | $0.76 | $0.39 | $0.58 | $0.27 | $0.33 | $0.36 | $0.24 |
| Gross margin | 19.5% | 19.9% | 19.9% | 20.4% | 20.4% | 20.0% | 20.5% | 20.5% |
| Operating margin | 6.1% | −5.1% | 3.9% | 5.7% | 3.8% | 4.4% | 4.9% | 4.3% |
| Net margin | 3.4% | −7.1% | 2.3% | 3.9% | 2.1% | 2.7% | 3.1% | 2.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $351.8M | $336.6M | $397.6M | $377.4M | $344.3M | $329.3M | $338.6M | $314.4M | $300.0M | $275.4M | $281.1M | $262.7M |
| Cost of revenue | $271.7M | $260.3M | $312.1M | $302.7M | $276.2M | $265.0M | $271.5M | $253.5M | $238.7M | $220.3M | $226.5M | $210.5M |
| Gross profit | $80.0M | $76.3M | $85.5M | $74.7M | $68.1M | $64.3M | $67.1M | $60.9M | $61.3M | $55.1M | $54.6M | $52.2M |
| Sales, general & admin | $59.4M | $58.6M | $54.7M | $58.4M | $55.6M | $51.3M | $45.9M | $165.5M | $44.3M | $47.2M | $15.6M | $58.5M |
| Total operating expenses | $59.4M | $58.6M | $48.9M | $57.9M | $55.6M | $51.3M | $50.3M | $165.5M | $44.3M | $47.2M | $39.1M | $58.5M |
| Operating income | $20.6M | $17.7M | $36.6M | $16.8M | $12.6M | $13.0M | $16.8M | −$104.6M | $17.0M | $7.9M | $15.5M | −$6.3M |
| Interest expense | $154,000 | $154,000 | $163,000 | $160,000 | $172,000 | $170,000 | $421,000 | $1.0M | $1.1M | $765,000 | $739,000 | $716,000 |
| Income before taxes | $29.8M | $18.3M | $31.1M | $16.6M | $12.6M | $13.1M | $16.2M | −$105.6M | $15.8M | $7.1M | $14.6M | −$7.0M |
| Income taxes | $7.7M | $4.7M | $9.8M | $7.0M | $3.8M | $3.8M | $4.4M | $176,000 | — | — | — | — |
| Net income | $21.9M | $13.3M | $20.9M | $9.8M | $9.0M | $9.4M | $11.9M | −$112.6M | $10.6M | $2.8M | $12.0M | −$11.3M |
| EBITDA | $35.8M | $24.4M | $37.0M | $22.6M | $18.2M | $18.5M | $21.8M | −$99.6M | $21.8M | $12.6M | $20.0M | −$1.6M |
| EPS (diluted) | $0.24 | $0.29 | $0.37 | $0.25 | $0.22 | $0.21 | $0.24 | $0.28 | $0.24 | — | — | — |
| Gross margin | 22.8% | 22.7% | 21.5% | 19.8% | 19.8% | 19.5% | 19.8% | 19.4% | 20.4% | 20.0% | 19.4% | 19.9% |
| Operating margin | 5.9% | 5.3% | 9.2% | 4.5% | 3.7% | 3.9% | 4.9% | −33.3% | 5.7% | 2.9% | 5.5% | −2.4% |
| Net margin | 6.2% | 3.9% | 5.3% | 2.6% | 2.6% | 2.9% | 3.5% | −35.8% | 3.5% | 1.0% | 4.3% | −4.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in GRDN's financial statements (latest annual report filed March 11, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
GRDN financial results
In fiscal year 2025 (ended December 31, 2025), Guardian Pharmacy Services reported revenue of $1.4 billion, up 17.9% from the year before. It had net income of $49.2 million, a net profit margin of 3.4%. Diluted earnings per share came to $1.05. Over five years revenue grew at an average rate of 14.5% a year.
See the GRDN stock overview for the latest quote and news, or the GRDN chart for price history and technical indicators.
GRDN income statement FAQ
What is Guardian Pharmacy Services's annual revenue?
Guardian Pharmacy Services reported total revenue of $1.4 billion for fiscal year 2025, which ended on December 31, 2025. That was up 17.9% from $1.2 billion the previous year.
Is Guardian Pharmacy Services profitable?
Yes. Guardian Pharmacy Services reported net income of $49.2 million in fiscal 2025, a net profit margin of 3.4%; its operating margin was 6.1%.
What is Guardian Pharmacy Services's gross margin?
Guardian Pharmacy Services's gross margin was 19.5% in fiscal 2025: for every $100 of revenue, Guardian Pharmacy Services kept $19 after the direct cost of its products and services.
How fast is Guardian Pharmacy Services growing?
Revenue grew 14.5% a year on average over the last five fiscal years, from $736.0 million to $1.4 billion.
What are Guardian Pharmacy Services's earnings per share?
Guardian Pharmacy Services earned $1.05 per diluted share in fiscal 2025, compared with $0.76 a year earlier.
When will Guardian Pharmacy Services report its next earnings?
Guardian Pharmacy Services is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes.
When does Guardian Pharmacy Services's fiscal year end?
Guardian Pharmacy Services's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 11, 2026.